Team:Tufts

From 2014.igem.org

(Difference between revisions)
Line 260: Line 260:
               </a><ul class="dropdown-menu">
               </a><ul class="dropdown-menu">
                 <li>
                 <li>
-
                   <a href="https://2013.igem.org/Team:Tufts/conference">
+
                   <a href="https://2014.igem.org/Team:Tufts/conference">
                     The Future of Phage and Synthetic Biology
                     The Future of Phage and Synthetic Biology
                   </a>
                   </a>
                 </li>
                 </li>
                 <li>
                 <li>
-
                   <a href="https://2013.igem.org/Team:Tufts/app_scenarios">
+
                   <a href="https://2014.igem.org/Team:Tufts/app_scenarios">
                   Application Scenarios
                   Application Scenarios
                   </a>
                   </a>
                 </li>
                 </li>
                 <li>
                 <li>
-
                   <a href="https://2013.igem.org/Team:Tufts/techno-moral_scenarios">
+
                   <a href="https://2014.igem.org/Team:Tufts/techno-moral_scenarios">
                   Techno-Moral Scenarios
                   Techno-Moral Scenarios
                   </a>
                   </a>
                 </li>
                 </li>
                 <li>
                 <li>
-
                   <a href="https://2013.igem.org/Team:Tufts/survey">
+
                   <a href="https://2014.igem.org/Team:Tufts/survey">
                   Survey
                   Survey
                   </a>
                   </a>
Line 290: Line 290:
             <li>
             <li>
-
               <a href="https://2013.igem.org/Team:IIT_Madras/sponsors">
+
               <a href="https://2014.igem.org/Team:Tufts/sponsors">
                 Sponsors
                 Sponsors
               </a>
               </a>
Line 324: Line 324:
          
          
         <div class="item active">
         <div class="item active">
-
           <img src="https://static.igem.org/mediawiki/2013/d/db/Iitm13_Slide_1.jpg" alt="Second slide" style="height: 500px; width: 100%; display: block;">
+
           <img src="https://static.igem.org/mediawiki/2014/d/db/Iitm13_Slide_1.jpg" alt="Second slide" style="height: 500px; width: 100%; display: block;">
           <div class="container">
           <div class="container">
             <div class="carousel-caption">
             <div class="carousel-caption">
Line 335: Line 335:
;
;
     padding-top: 10px;
     padding-top: 10px;
-
">COMBATING SHIGA TOXIN</marquee>
+
">BIOFILM ENHANCEMENT</marquee>
             </div>
             </div>
           </div>
           </div>
Line 345: Line 345:
         <div class="item">
         <div class="item">
-
           <img src="https://static.igem.org/mediawiki/2013/f/f5/Iitm13_Slide_2.jpg" alt="Third slide" style="height: 500px; width: 100%; display: block;">
+
           <img src="https://static.igem.org/mediawiki/2014/f/f5/Iitm13_Slide_2.jpg" alt="Third slide" style="height: 500px; width: 100%; display: block;">
           <div class="container">
           <div class="container">
             <div class="carousel-caption">
             <div class="carousel-caption">
Line 353: Line 353:
         </div>
         </div>
<div class="item">
<div class="item">
-
           <img src="https://static.igem.org/mediawiki/2013/a/a7/Iitm13_Slide_3.jpg" alt="Third slide" style="height: 500px; width: 100%; display: block;">
+
           <img src="https://static.igem.org/mediawiki/2014/a/a7/Iitm13_Slide_3.jpg" alt="Third slide" style="height: 500px; width: 100%; display: block;">
           <div class="container">
           <div class="container">
             <div class="carousel-caption">
             <div class="carousel-caption">
Line 361: Line 361:
         </div>
         </div>
<div class="item">
<div class="item">
-
           <img src="https://static.igem.org/mediawiki/2013/4/4f/Iitm13_Slide_4.jpg" alt="Third slide" style="height: 500px; width: 100%; display: block;">
+
           <img src="https://static.igem.org/mediawiki/2014/4/4f/Iitm13_Slide_4.jpg" alt="Third slide" style="height: 500px; width: 100%; display: block;">
           <div class="container">
           <div class="container">
             <div class="carousel-caption">
             <div class="carousel-caption">
Line 371: Line 371:
         </div>
         </div>
<div class="item">
<div class="item">
-
           <img src="https://static.igem.org/mediawiki/2013/b/b8/Last_slide_edit.jpg" alt="Third slide" style="height: 500px; width: 100%; display: block;">
+
           <img src="https://static.igem.org/mediawiki/2014/b/b8/Last_slide_edit.jpg" alt="Third slide" style="height: 500px; width: 100%; display: block;">
           <div class="container">
           <div class="container">
             <div class="carousel-caption">
             <div class="carousel-caption">
Line 387: Line 387:
       <div class="row featurette">
       <div class="row featurette">
         <div class="col-md-7">
         <div class="col-md-7">
-
           Shiga toxin, a worldwide menace, has killed over 1 million people to date and continues to afflict almost 150 million people each year. Currently, there is no treatment for Shiga toxicosis and it leads to complications in the human system like hemolytic uremic syndrome (HUS) and renal failure. Here, we propose a two-fold, novel synthetic biology approach to combat the lethal effect of the toxin. We aim to neutralize the already produced toxin through a nine amino acid Gb3 mimic peptide. We have engineered the Gb3 mimic along with a cellular export signal (ompF) downstream of AHL(quorum sensing molecule) inducible promoter (pLuxR). We also plan to prevent further toxin production by inhibiting the biofilm formation of shigatoxigenic E.coli using indole-3-acetaldehyde (I3A). We expect to validate our approach through functional assays and in silico modelling. Our findings can potentially initiate a new perspective of tackling Shiga toxicosis using synthetic biology tools.
+
           A long, noncoding massively expressed regulatory RNA (merRNA) discovered in Bdellovibrio bacteriovorus is present in high levels during its dormant phase. The merRNA is believed to sequester cyclic-di-GMP, much like a sponge. Since cyclic-di-GMP is a second messenger for various cellular functions, including motility and biofilm formation, the Tufts iGEM team introduced this merRNA sequence into E. coli. Constitutive expression of this merRNA transcript was shown to increase biofilm formation. This property can be useful in microbe-based approaches to environmental remediation. Earlier designs for phage delivery of the merRNA to disrupt biofilms inspired an investigation into the policy surrounding engineered bacteriophage. Tufts iGEM will be convening a panel of experts from various disciplines to put forth recommendations for the responsible use of phage in therapeutic and industrial applications. A proposal will be drafted for a silk bandage containing a phage cocktail which can prevent and treat infection by antibiotic-resistant bacteria.
       </div>
       </div>
<div class="col-md-3">
<div class="col-md-3">
-
<img src="https://static.igem.org/mediawiki/2013/6/61/Iitm13_team_pic.JPG" width="100%" style="
+
<img src="https://static.igem.org/mediawiki/2014/6/61/Iitm13_team_pic.JPG" width="100%" style="
     padding-top: 33px;
     padding-top: 33px;
     width: 458px;
     width: 458px;

Revision as of 03:36, 10 October 2014

Tufts University
A long, noncoding massively expressed regulatory RNA (merRNA) discovered in Bdellovibrio bacteriovorus is present in high levels during its dormant phase. The merRNA is believed to sequester cyclic-di-GMP, much like a sponge. Since cyclic-di-GMP is a second messenger for various cellular functions, including motility and biofilm formation, the Tufts iGEM team introduced this merRNA sequence into E. coli. Constitutive expression of this merRNA transcript was shown to increase biofilm formation. This property can be useful in microbe-based approaches to environmental remediation. Earlier designs for phage delivery of the merRNA to disrupt biofilms inspired an investigation into the policy surrounding engineered bacteriophage. Tufts iGEM will be convening a panel of experts from various disciplines to put forth recommendations for the responsible use of phage in therapeutic and industrial applications. A proposal will be drafted for a silk bandage containing a phage cocktail which can prevent and treat infection by antibiotic-resistant bacteria.

Retrieved from "http://2014.igem.org/Team:Tufts"